Helicobacter pylori determinants of pathogenicity

Journal of Chemotherapy

Volumn 11, Issue 6, 1999, Pages 591-600

  Figura, Natale ^a   Valassina, M ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

CagA; Chronic gastritis; Gastric cancer; H. pylori infection; Helicobacter pylori; Peptic ulcer; Urease; VacA

Indexed keywords

BACTERIAL TOXIN; CYTOTOXIN; UREASE;

BACTERIAL GENE; BACTERIAL VIRULENCE; CONFERENCE PAPER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PATHOGENESIS; PATHOGENICITY; STOMACH CANCER; STOMACH ULCER;

EID: 0033397219     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1999.11.6.591     Document Type: Conference Paper

References (67)

1. 1 Graham D. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615-25.
2. 2 Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric adenocarcinoma. N Engl J Med 1991; 325: 1127-31.
3. 3 Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-71.
4. 4 Tomb J-F, White O, Kerlavage AR, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997; 388: 539-47.
5. 5 Hancock REW, Alm R, Bina J, Trust T. Helicobacter pylori: a surprisingly conserved bacterium. Nature Biotechnol 1998; 16: 216-7.
6. 6 Covacci A, Rappuoli R. Helicobacter pylori: molecular evolution of a bacterial quasi-species. Curr Opinion Microbiol 1998; 1: 96-102.
7. 7 Censini S, Lange C, Xiang Z, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and diseases-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-53.
8. 8 Scott DR, Weeks D, Hong C, Postius S, Melchers K, Sachs G. The role of internal urease in acid resistance of Helicobacter pylori. Gastroenterology 1998; 114: 58-70.
9. 9 Phadnis SH, Parlow MH, Levy M, et al. Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis. Infect Immun 1996; 64: 905-12.
10. 10 Krishnamurthy P Parlow M, Zitzer J, Vakil N, Phadnis SH, Dunn BE. H. pylori containing only cytoplasmic urease are acid sensitive. Gastroenterology 1997; 112 (suppl): A185.
11. 11 Bijlsma JJE, Gerrits MM, Kuipers EJ, Vandenbroucke-Grauls CMJE, Kusters JG. A urease-independent acid resistance mechanism of Helicobacter pylori. Gastroenterology 1997; 112 (suppl): A935.
12. 12 Figura N. Helicobacter pylori factors involved in the development of gastroduodenal mucosal damage and ulceration. J Clin Gastroenterol 1997; 25 (suppl. 1): S149-S163.
13. 13 Katsuaki K, Sasano H, Ohara S, et al. DNA damages caused by ammonia administration in rat stomach. Gastroenterology 1996; 110 (suppl): A150.
14. 14 Shibahara T, Yanaka A, Muto M, et al. Ammonia and hypoxia induces apoptosis of duodenal enterocytes and retards restitution of injured guinea pig duodenal mucosae in vitro. Gastroenterology 1997; 112 (suppl): A288.
15. 15 Kaneko H. Deng w, Yamamoto S, et al. Helicobacter pylori-related urease-ammonia or histamine-3 receptor mediated suppression of rat gastric somatostatin release in vitro. Gastroenterology 1997; 112 (suppl): A166.
16. 16 Wiedmann B, Klauck S, Kircheis G, Günther I, Malfertheiner P. The influence of the Helicobacter pylori-infection on the ammonia levels and psychometric tests in cirrhotic patients. Gastroenterology 1997; 112 (suppl): A1415.
17. 17 Figura N. Helicobacter pylori exotoxins and gastroduodenal diseases associated with cytotoxic strain infection. Aliment Pharmacol Ther 1996; 10 (suppl. 1): 79-96.
18. 18 Telford JL, Ghiara P, Dell'Orco M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994; 179: 1653-8.
19. 19 Telford JL, Covacci A, Ghiara P, Montecucco C, Rappuoli R. Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer: potential foe new therapies and vaccines. Trends Biotechnol 1994; 12: 420-6.
20. 20 Lupetti P, Heuser JE, Manetti R, et al. Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J Cell Biol 1996; 133: 801-7.
21. 21 Cover TL, Hanson PI, Heuser JE. Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin, reveals its pattern of assembly. J Cell Biol 1997; 138: 759-69.
22. 22 Papini E, Bugnoli M, De Bernard M, Figura N, Rappuoli R, Montecucco C. Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolation of HeLa cells. Mol Microbiol 1993; 7: 323-7.
23. 23 Ricci V, Somrni P, Cova R, et al. Na+,K+-ATPase of gastric cells. A target of Helicobacter pylori cytotoxic activity. FEBS Lett 1993; 334: 158-60.
24. 24 Kobayashi H, Kamiya S, Suzuki T, et al. The effect of Helicbacter pylori on gastric acid secretion by isolated parietal cells from a guinea pig. Scand J Gastroenterol 1996; 31: 428-33.
25. 25 Molinari M, Galli C, Norais N, et al. Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers. J Biol Chem 1997; 272: 25339-44.
26. 26 Satin B, Norais N, Telford J, et al. Effect of Helicobacter pylori vacuolating toxinon maturation and extracellular release of procathepsin D and on epidermal growth factor degradation. J Biol Chem 1997; 272: 25022-8.
27. 27 Ashorn M, Cantet F, Mégraud F. Cytoskeletal rearrangements induced by Helicobacter pylori strains in epithelial cell culture - Role of the cytotoxin. Gastroenterology 1997; 112 (suppl): A612.
28. 28 Brzozowski T, Konturek PCH, Karczewska E, et al. The mouse model of infection with cytotoxin expressing strain of Helicobacter pylori (Hp) in studying the pathogenesis of chronic gastric ulcer. Gut 1996; 39 (suppl 2): A75.
29. 29 Romano M, Ricci V, Sommi P, et al. Helicobacter pylori inhibits the proliferative effect of amphiregulin and heparin binding epidermal growth factor-like growth factor in MKN28 Gastric mucosal cells. Gastroenterology 1997; 112 (suppl): A272.
30. 30 Fujiwara Y, Wyle F, Arakawa T, et al. H.P. toxin reduces EGF binding to its receptor and proliferative response of human gastric Kato III cells to EGF stimulation. Important mechanism for H.P. interference with the ulcer healing? Gastroenterology 1995; 108 (suppl): A97.
31. 31 Romano M, Ricci V, Zarrilli R, et al. Helicobacter pylori and gastric mucosa healing: an in vitro study on the role of VacA and CagA . It J Gastroenterol 1995; 27 (suppl 1): 221.
32. 32 Pai R, Wyle FA, Cover TL, Itani RM, Domek M, Tarnawski A. H. pylori vacA cytotoxin interferes with EGF activated signal transduction cascade in human gastric Kato III cells. Gastroenterology 1997; 112 (suppl): A250.
33. 33 Sandor Z, Vincze Á, Jadus M, et al. Effect of vac+ and vac-Helicobacter pylori (Hp) supematants on the bioactivity of basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) in vitro. Gastroenterology 1996; 110 (suppl): A249.
34. 34 Watanabe S, Wang XE, Horose M, Murai T, Ohkura R, Sato N. Hepatocyte growth factor prevents the retardation of gastric epithelial repair, but not for vacuolisation, induced by Helicobacter pylori water extract in vivo. Gastroenterology 1997; 112 (suppl): A327.
35. 35 Konturek PCh, Ernst H, Bobrzynski A, et al Salivary and gastric epidermal growth factor (EGF) and gastric mucosal EGF expression in duodenal ulcer (DU) patients before and after eradication of Helicobacter pylori. Gastroenterology 1996; 110 (suppl): A161.
36. 36 Molinari M, Salio M, Galli C, et al. Selective inhibition of I-i-dependent antigen presentation by Helicobacter pylori toxin VacA. J Exp Med 1998; 187: 135-40.
37. 37 Atherton JC, Coa P, Peek RM Jr, Tummuru MKR, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem 1995; 270: 17771-7.
38. 38 Atherton JC, Peek RM Jr., Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997; 112: 92-9.
39. 39 Navaglia F, Basso D, Piva MG, et al. Helicobacter pylori cytotoxic genotype Is associated with peptic ulcer and influences serology. Am J Gastroenterol 1998; 93: 227-30.
40. 40 Cover TL, Tummuru MKR, Cao P, Thompson SA, Blaser MJ. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994; 269: 10566-73.
41. 41 Pagliaccia C, de Bernard M, Lupetti P, et al. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vaculating activity. Proc Natl Acad Sci 1998; 95: 10212-7.
42. 42 Murakita H, Hirai M, Ito S, et al. Cytotoxin and urease activities of Helicobacter pylori isolates from Japanese patients with atrophie gastritis or duodenal ulcer. J Gastroenterol Hepathol 1996; 11: 819-24.
43. 43 Ito Y, Azuma T, Ito S, et al. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol 1997; 35: 1710-4.
44. 44 Xiang Z, Censini S, Bayeli PF, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that the clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating toxin. Infect Immun 1995; 63: 94-8.
45. 45 Segal ED, Falkow S, Tompkins LS. Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cells proteins. Proc Natl Acad Sci USA 1996; 93: 1259-64.
46. 46 Segal ED, Lange C, Covacci A, Tompkins LS, Falkow S. Induction of host signal transduction pathways by Helicobacter pylori. Proc Natl Acad Sci USA 1997; 94: 7595-9.
47. 47 Ding S-Z, Cho C-H, Lam S-K. Helicobacter pylori induces interleukin-8 expression in endothelial cells and the signal pathway is protein tyrosine kinase dependent. Biochem Biophys Res Commun 1997; 240: 561-5.
48. 1. J Immunol 1997; 159: 6140-7.
49. 49 Keates S, Hitti YS, Upton M, Kelly CP. Helicobacter pylori infection activates NF-kB in gastric epithelial cells. Gastroenterology 1997; 113: 1099409.
50. 50 Romagnani S, Parronchi P, D'Elios M, et al. Immune mechanisms in the pathogenesis of inflammatory gastrointestinal disorders. Ital J Gastroenterol 1996, 28 (suppl. 2): 11-7.
51. 51 Bamford KB, Fan X, Crowe SE, et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998; 114: 482-92.
52. 52 Ernst PB, Crowe SE, Reyes VE. How does Helicobacter pylori cause mucosal damage? The inflammatory response. Gastroenterology 1997; 113: S35-S42.
53. 53 Jones NL, Shannon PT, Cutz E, Yeger H, Sherman PM. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 1997; 151: 1695-703.
54. 54 Fan XJ, Gunasena H, Ye G, Crowe SE, Ernst PB. Helicobacter pylori binding to class II MHC molecules on human gastric epithelial cells causes epithelial apoptosis. Gastroenterology 1997; 112 (suppl): A968.
55. 55 Rudi J, Kuck D, Krammer PH, Stremmel W, Galle PR. Possible involvement of the APO-1/Fas (CD95) receptor/lig-and system in H. pylori induced apoptosis. Gastroenterology 1997; 112 (suppl): A274.
56. 56 Jones NL, Yeger H, Sherman PM. Elucidation of mechanisms involved in Helicobacter pylori-induced apoptosis in vitro: role of FAS/FAS ligand signaling. Gastroenterology 1997; 112 (suppl): A1007.
57. 57 Haham KB.Lee KJ, Kim YS, et al. Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide. Dig Dis Sci 1998; 43: 235-40.
58. 58 Peek RM, Moss SF, Tham KT, et al. Infection with H. pylori cagA+ strains dissociates gastric epithelial proliferation from apoptosis. J Natl Cancer Inst 1997; 89: 863-8.
59. 59 Ashktorab H, Allen CR, Reeves B, Smoot DT. Regulation of apoptosis by differential expression of wafl, p53 and bc12 in gastric cells exposed to H. pylori. Gastroenterology 1997; 112 (suppl): A534.
60. 60 Figura N, Vindigni C, Covacci A, et al. cagA positive and negative Helicobacter pylori strains are simultaneously present in the stomach of most patients with non-ulcer dyspepsia: relevance tohistological damage. Gut 1998; 42: 772-8.
61. 61 Fantry GT, Zheng QX, Darwin PE, Rosentstein AH, James SP. Mixed infection with cagA positive and cagA negative strains of Helicobacter pylori. Helicobacter 1996; 1: 98-106.
62. 62 van der Ende A, Rauws EAJ, Feller M, Mulder CJJ, Tytgat GNJ, Dankert J. Heterogeneous Helicobacter pylori isolates from members of a family with a history of peptic ulcer disease. Gastroenterology 1996; 111: 638-47.
63. 63 Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-KDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5.
64. 64 Miehlke S, Kibler K, Kim JG, et al. Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol 1996; 91: 1322-5.
65. 65 Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR. Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol 1998; 36: 2258-63.
66. 66 Sepulveda AR, Dore MP, Gutierrez O, et al. Helicobacter pylori CagA proteins of higher size are associated with gastric carcinoma. Gut 1997; 41 (suppl 1): A112.
67. 67 Ilver D, Arnqvist A, Ögren J, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998; 279: 373-7.